Companies/US/MDXG

MIMEDX GROUP, INC.

Income flow

Annual
MDXG 10-K Income StatementPeriod 2025-12-31Source 10-K
Wound$276MSurgical$142MRevenue$419M+20% Y/YGross profit$346M+20% Y/YCost of revenue$73MOperating profit$64M+9% Y/YOther income$2MOperating expenses$282MPre-tax profit$66MSG&A$266MR&D & other$16MNet profit$49M+15% Y/YTax$18M

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Revenue mix

2025-12-31 · 10-K · USD
By activity
By activity$419M
  • Wound$276M66.0%
  • Surgical$142M34.0%

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).0.00%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.0.0%Shares outTotal shares currently outstanding (issued and not retired).145.9MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).114.8M
Stock splits
  1. 3235:100002008-04-02

Valuation

Trailing PE 21.2 (2025-12-31)PE trend

Fiscal PE3

PeriodEPSClosePE
2025-12-310.326.7721.2
2024-12-310.289.6234.4
2023-12-310.378.7723.7

PE = stored close ÷ as-filed diluted EPS (annual 10-K / 20-F). Not a vendor PE series.